# Peer Schatz

> Peer Schatz is a seed investor in Düsseldorf backing Medical and Health Care. See 2 investments, round sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Location: Düsseldorf, Germany
- Total investments: 2
- Last investment: Jun 2022
- Lead investor: 0%
- Last updated: Aug 2026

Peer Schatz is a seed investor in Düsseldorf focused on Medical and Health Care. 1989, Master's in Finance, Univ. of St Gallen, Switzerland; 1991, MBA in Finance, Graduate School of Business, Univ. of Chicago. Former: Partner, private management buy-out group, Switzerland; finance and systems positions, Sandoz and Computerland; finance, operations, management and sales positions, computer and software trading start-upcompanies, Europe, US. 1993, joined QIAGEN, when the company had just 30 employees and revenues of approximately $2 million. Former Member, German Corporate Governance Commission. Director: AdvaMedDx (US in-vitro diagnostics industry organization); ALDA (Analytical, Life Science & Diagnostics Association).

## Contacts

5 contacts available for Peer Schatz: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/peer-schatz?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 100% |
| Health Care | 2 | 100% |
| Genetics | 1 | 50% |
| Oncology | 1 | 50% |
| Biotechnology | 1 | 50% |

8 industries tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 1 | 50% |
| United Kingdom | 1 | 50% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Relation Therapeutics | Relation Therapeutics is a biotechnology company that focuses on humanizing drug discovery and development. It leverages human genetics and clinical omics data and utilizes patient-derived tissue samples with functional genomics interventional experiments to identify, validate, and prosecute therapeutic programs. | $25M | Seed | Jun 09, 2022 | https://www.relationrx.com/ |
| Valar Labs | Valar Labs makes AI to interpret solid tumors and deliver insights, so physicians and patients can make informed treatment decisions. Their AI algorithms analyze digitized pathology slides to assess spatial features, and they design transparent systems grounded in underlying biology so physicians can trust the results. | $4M | Seed | Mar 30, 2022 | https://www.valarlabs.com/ |

2 of 2 investments shown.

## Co-investors
- [Andreessen Horowitz](https://shizune.co/investors/profile/andreessen-horowitz) — VC Fund, 1 deal together
- [DCVC](https://shizune.co/investors/profile/data-collective) — VC Fund, 1 deal together
- [Firstminute Capital](https://shizune.co/investors/profile/firstminute-capital) — VC Fund, 1 deal together
- [Khosla Ventures](https://shizune.co/investors/profile/khosla-ventures) — VC Fund, 1 deal together
- [Magnetic Ventures](https://shizune.co/investors/profile/magnetic-ventures) — VC Fund, 1 deal together
- [OMERS Ventures](https://shizune.co/investors/profile/omers-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [Fuel Ventures](https://shizune.co/investors/profile/fuel-ventures-fund) — VC Fund
- [Business Growth Fund](https://shizune.co/investors/profile/business-growth-fund) — VC Fund

## Featured in investor lists
- [Biotech Angel Investors in United Kingdom](https://shizune.co/investors/biotech-angel-investors-united-kingdom)
- [Medical Angel Investors in United Kingdom](https://shizune.co/investors/medical-angel-investors-united-kingdom)
- [Biotechnology Angel Investors in United Kingdom](https://shizune.co/investors/biotechnology-angel-investors-united-kingdom)

## FAQ

### What does Peer Schatz invest in?

Peer Schatz invests primarily in Medical, Health Care and Genetics startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Peer Schatz?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Peer Schatz last invest?

The most recent investment recorded for Peer Schatz closed in Jun 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co